510(k) K122688
K122688 is an FDA 510(k) premarket notification submitted by Nova Biomedical Corporation for the device "NOVA MAX MINI BLOOD GLUCOSE AND B-KETONE MONITOR". The FDA issued a decision of Substantially Equivalent on April 4, 2013. The device falls under product code LFR (Glucose Dehydrogenase, Glucose), a Class II device regulated under 21 CFR 862.1345. Nova Biomedical Corporation has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 4, 2013
- Date Received
- September 4, 2012
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Glucose Dehydrogenase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type